Downregulation of the fibrinogen gamma chain has been associated with reduced resistance to anthracycline chemotherapy in breast cancer [81], and silencing of this chain has been shown to markedly increase apoptosis and reduce the proliferation, invasion, and migration of cancer cells [82]. This evidence concerns the gene FGG and breast cancer.